Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines

• Prif Awduron: Susanna Nencetti (Awdur), Doretta Cuffaro (Awdur), Elisa Nuti (Awdur), Lidia Ciccone (Awdur), Armando Rossello (Awdur), Marina Fabbi (Awdur), Flavio Ballante (Awdur), Gabriella Ortore (Awdur), Grazia Carbotti (Awdur), Francesco Campelli (Awdur), Irene Banti (Awdur), Rosaria Gangemi (Awdur), Garland R. Marshall (Awdur), Elisabetta Orlandini (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Uveal melanoma (UM) represents an aggressive type of cancer and currently, there is no effective treatment for this metastatic disease. In the last years, histone deacetylase inhibitors (HDACIs) have been studied as a possible therapeutic treatment for UM, alone or in association with other chemothe...